Farmaceutica REMEDIA Statistics

Total Valuation

Farmaceutica REMEDIA has a market cap or net worth of RON 58.53 million. The enterprise value is 28.57 million.

Market Cap	58.53M
Enterprise Value	28.57M

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Sep 11, 2024

Share Statistics

Farmaceutica REMEDIA has 92.32 million shares outstanding. The number of shares has decreased by -0.29% in one year.

Current Share Class	n/a
Shares Outstanding	92.32M
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	-45.69%
Owned by Insiders (%)	84.24%
Owned by Institutions (%)	0.29%
Float	14.55M

Valuation Ratios

The trailing PE ratio is 22.89.

PE Ratio	22.89
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.64
P/TBV Ratio	0.89
P/FCF Ratio	5.61
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.91, with an EV/FCF ratio of 2.74.

EV / Earnings	10.82
EV / Sales	0.04
EV / EBITDA	2.91
EV / EBIT	5.15
EV / FCF	2.74

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.02.

Current Ratio	1.09
Quick Ratio	0.92
Debt / Equity	0.02
Debt / EBITDA	0.15
Debt / FCF	0.15
Interest Coverage	35.80

Financial Efficiency

Return on equity (ROE) is 3.96% and return on invested capital (ROIC) is 5.53%.

Return on Equity (ROE)	3.96%
Return on Assets (ROA)	1.18%
Return on Capital (ROIC)	5.53%
Revenue Per Employee	3.10M
Profits Per Employee	11,486
Employee Count	230
Asset Turnover	2.22
Inventory Turnover	15.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.93% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.93%
50-Day Moving Average	0.68
200-Day Moving Average	0.72
Relative Strength Index (RSI)	40.45
Average Volume (20 Days)	18,382

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Farmaceutica REMEDIA had revenue of RON 713.81 million and earned 2.64 million in profits. Earnings per share was 0.03.

Revenue	713.81M
Gross Profit	34.53M
Operating Income	6.08M
Pretax Income	8.21M
Net Income	2.64M
EBITDA	10.19M
EBIT	6.08M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 31.51 million in cash and 1.55 million in debt, giving a net cash position of 29.95 million or 0.32 per share.

Cash & Cash Equivalents	31.51M
Total Debt	1.55M
Net Cash	29.95M
Net Cash Per Share	0.32
Equity (Book Value)	66.89M
Book Value Per Share	1.00
Working Capital	26.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.85 million and capital expenditures -1.41 million, giving a free cash flow of 10.44 million.

Operating Cash Flow	11.85M
Capital Expenditures	-1.41M
Free Cash Flow	10.44M
FCF Per Share	0.11

Full Cash Flow Statement

Margins

Gross margin is 4.84%, with operating and profit margins of 0.85% and 0.37%.

Gross Margin	4.84%
Operating Margin	0.85%
Pretax Margin	1.15%
Profit Margin	0.37%
EBITDA Margin	1.43%
EBIT Margin	0.85%
FCF Margin	1.46%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 7.89%.

Dividend Per Share	0.05
Dividend Yield	7.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	162.38%
Buyback Yield	0.29%
Shareholder Yield	8.17%
Earnings Yield	4.37%
FCF Yield	17.83%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Farmaceutica REMEDIA has an Altman Z-Score of 2.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.39
Piotroski F-Score	n/a